Diagnosis

Plasma Viremia Linked to HIV Disease Progression

Published in AIDS Weekly, July 17th, 1995

Persistent, increased, or reappearing plasma viremia predicts a poor clinical outcome in patients receiving zidovudine (AZT) for HIV disease, clinical data suggest.

These findings indicate that clinicians may wish to change antiretroviral regimens based on quantification of HIV burden in plasma.

Researchers A. Ruffault and colleagues of Pontchaillou Hospital, Rennes, France, evaluated HIV-1 plasma viremia in 28 patients with HIV infection before and after long-term AZT treatment. They reported their findings in the July 1995 issue of the Journal of Acquired Immune Deficiency Syndromes ("The Prognostic Value of Plasma Viremia in HIV-Infected Patients...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry